Caina Technology Co

Caina Technology Co Accounts Payable

The Accounts Payable of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 91.44 M CNY. In the previous year, Accounts Payable was 109.16 M CNY — a change of -16.24% (lower).

Accounts Payable

91.44 MCNY

YoY

-16.24%

Last updated:

Accounts Payable of Caina Technology Co is 2025 91.44 M CNY. Accounts Payable of Caina Technology Co was 2024 109.16 M CNY. It decreases by -16.24% lower compared to the previous year.

The Caina Technology Co Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2018
31.86 M CNY
Jan 1, 2019
19.81 M CNY
Jan 1, 2020
45.04 M CNY
Jan 1, 2021
65.03 M CNY
Jan 1, 2022
76.35 M CNY
Jan 1, 2023
88.68 M CNY
Jan 1, 2024
109.16 M CNY
Jan 1, 2025
91.44 M CNY
The Caina Technology Co Accounts Payable history
YEARAccounts PayableYoY
91.44 MCNY-16.24%
109.16 MCNY+23.10%
88.68 MCNY+16.15%
76.35 MCNY+17.42%
65.03 MCNY+44.37%
45.04 MCNY+127.34%
19.81 MCNY-37.81%
31.86 MCNY+9.51%
29.09 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Accounts Payable of Caina Technology Co is 91.44 M CNY in 2025.

Accounts Payable of Caina Technology Co changed from 109.16 M CNY to 91.44 M CNY, representing a -16.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Caina Technology Co

All Key Metrics — Caina Technology Co